Examkin

Soru

Zorluk: ZorInfectious Diseases

A 26-year-old woman presents to the clinic for sexually transmitted infection screening. She reports having condomless sexual intercourse with a new male partner three weeks ago. She recently learned that this partner is living with HIV and is not taking any medications. She currently feels well and has no symptoms of acute illness. Vital signs and physical examination are unremarkable. The physician decides to evaluate her for HIV. Assuming her initial screening test is reactive, but her subsequent confirmatory antibody test is indeterminate, arrange the following diagnostic and management steps in the correct chronological sequence according to the standard Centers for Disease Control and Prevention (CDC) HIV algorithm.

  1. 1Perform an HIV-1/2 antigen/antibody combination immunoassay
  2. 2Perform an HIV-1/HIV-2 antibody differentiation immunoassay
  3. 3Perform an HIV-1 nucleic acid test (NAT)
  4. 4Initiate antiretroviral therapy (ART) and obtain a baseline CD4 cell count

Cevap

The correct sequence begins with the HIV-1/2 antigen/antibody combination immunoassay, followed by the HIV-1/HIV-2 antibody differentiation immunoassay. Due to the indeterminate result, an HIV-1 nucleic acid test (NAT) is performed next. Finally, antiretroviral therapy (ART) is initiated and baseline labs are drawn.
The correct sequence precisely follows the CDC diagnostic algorithm for HIV. The first step is the highly sensitive fourth-generation antigen/antibody combination test. If reactive, the second step is the differentiation assay to determine if the patient has HIV-1 or HIV-2 antibodies. Because this patient is in the acute phase of infection (only 3 weeks post-exposure), she has p24 antigenemia but has not yet developed a mature antibody response, resulting in a reactive step 1 but an indeterminate step 2. This specific discrepancy mandates step 3, an HIV-1 nucleic acid test (NAT), to detect viral RNA and confirm acute HIV-1 infection. Once the diagnosis is definitively confirmed by a positive NAT, step 4 is to initiate antiretroviral therapy (ART) and obtain baseline immunologic and virologic studies such as a CD4 count.

Adım Adım Çözüm

1
Perform the HIV-1/2 antigen/antibody combination immunoassay.
The test returns a reactive result.
This fourth-generation test is the highly sensitive initial screening tool mandated by the CDC algorithm, detecting both p24 antigen and antibodies.
2
Perform the HIV-1/HIV-2 antibody differentiation immunoassay.
The test returns an indeterminate result.
All reactive initial screens must be followed by this test to confirm infection and differentiate the viral type. The indeterminate result occurs because the patient is in the acute window phase (p24 antigen is present, but mature antibodies have not yet formed).
3
Perform an HIV-1 nucleic acid test (NAT).
The NAT returns a positive result for HIV-1 RNA.
NAT is required to resolve the discrepancy between the reactive combination test and the indeterminate differentiation test, confirming the diagnosis of acute HIV-1 infection.
4
Initiate antiretroviral therapy (ART) and obtain a baseline CD4 cell count.
The patient is started on a modern ART regimen.
Once the diagnosis is definitively confirmed via NAT, prompt initiation of ART is standard of care to suppress viral replication, preserve immune function, and prevent transmission.

Anahtar Kavram

Standard CDC HIV Diagnostic Algorithm and Identification of Acute HIV Infection
Bu soruyu puanla

Konular

Infectious Diseases

Bu konudan daha fazla soru